Is there a relationship between serum uric acid and prostate-specific antigen in middle-aged and elderly Chinese men?

Table 2 Association between SUA and PSA

SUA (μmol/L)	Elevated PSA	Normal PSA	OR (95% CI)
SUA (μmol/L)	Elevated PSA	Normal PSA	Model 1^a	Model 2^b	Model 3^c	Model 4^d	Model 5^e
Quartile 1 (≤ 288)	141(58.02%)	102(41.98%)	1.00	1.00	1.00	1.00	1.00
Quartile 2 (289–343)	162(66.94%)	80(33.06%)	1.47 (1.01–2.12)	1.44 (0.99–2.09)	1.42 (0.98–2.06)	1.45 (0.99–2.11)	1.42 (0.97–2.08)
Quartile 3 (344–399)	165(68.46%)	76(31.54%)	1.57 (1.08–2.28)	1.53 (1.05–2.22)	1.45 (0.99–2.13)	1.52 (1.04–2.23)	1.45 (0.98–2.13)
Quartile 4 (≥ 400)	165(68.46%)	76(31.54%)	1.57 (1.08–2.28)	1.51 (1.04–2.20)	1.41 (0.96–2.08)	1.35 (0.90–2.03)	1.26 (0.83–1.90)
P for trend			0.016	0.029	0.083	0.120	0.259

SUA, serum uric acid; PSA, prostate-specific antigen; OR, odds ratios; CI, confidence interval; FBG, fasting blood glucose; TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; Cr, creatinine; BUN, blood urea nitrogen; GFR, glomerular filtration rate
^aModel 1: Crude model, no adjustment
^bModel 2: Adjusted for age and FBG
^cModel 3: Based on Model 2, additionally adjusted for TC, TG, HDL-C and LDL-C
^dModel 4: Based on Model 2, additionally adjusted for Cr, BUN and GFR
^eModel 5: Based on Model 3, further adjusted for Cr, BUN and GFR

ISSN: 2047-783X